Efficacy and safety of once-weekly semaglutide monotherapy versus placebo in patients with type 2 diabetes (SUSTAIN 1): a double-blind, randomised, placebo-controlled, parallel-group, multinational, multicentre phase 3a trial. The Lancet Diabetes & Endocrinology, vol
Currently, there is no direct evidence that GLP-1RA use contributes to progression of pancreatic cysts to PDAC, but this remains an important knowledge gap for future investigations considering the high prevalence of pancreatic cysts in the general population (~ 10% by age 50 and ~25% by age 70) 56
Insurance coverage questions may depend on diagnosis, plan rules, and whether treatment is being considered for weight management, type 2 diabetes, or another clinical reason
The lawsuits claimed mothers who took over-the-counter acetaminophen during pregnancy may have an increased risk of their children developing ASD or ADHD